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As the fields of quality assessment and improvement become integral parts of medical practice, the roles of
National Medical Associations, and other physician organizations in these endeavors have undergone major
changes in scope and intensity as well. The survey based report in this journal by Levi et al. suggests some major
overall trends but also notes wide variation from country to country. In this commentary, we touch on some likely
reasons for the variation seen in the focus of physician organization participation in quality activities, and offer
some suggestions for why expanded involvement by physician organizations may be critical to quality efforts going
forward.Historical evolution of quality in healthcare
systems
The article by Levi and his colleagues [1] related to the
role of National Medical Associations in different coun-
tries in the area of quality is perhaps most notable for its
finding that there is not a clear and consistent role of
NMA’s across the 22 countries that participated in the
survey. Also evident was the wide variation in how dif-
ferent the roles are that public and private sector entities
play in assessing, measuring, influencing or regulating
and assuring clinical quality. Using the US as an ex-
ample, I will explore why the roles of NMAs may have
diverged as the current chaos of quality approaches
evolved (at least in the US), and end with some thoughts
about what roles NMAs and specialty societies might
best play going forward.
The recognition of problems related to health care
quality, and how to address them, has seemed to be ra-
ther slow and uneven both within and between coun-
tries. Some of this appears to have been a result of the
way in which health care itself has developed in different
areas of the world, especially in regard to public versus
private models of financing, delivery and payment. In
addition, with a few notable exceptions, up until fairly
late in the 20th century, quality in health care was as-
sumed by most to be uniformly high and assured by pro-
fessionalism within medicine, nursing and other healthCorrespondence: Gpawlson@gmail.com
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unless otherwise stated.professions. Those like Florence Nightingale in nursing,
and Ernest Codman in medicine, who empirically docu-
mented results that suggested major problems in quality
within healthcare, were largely ignored or even, in some
instances, vilified.
In this period, professionalism did have important im-
pacts on quality, but this was largely restricted to re-
forms in medical education. For example, in the US in
the early 1900′s, the Flexner report and subsequent
changes in medical education led to the creation of a set
of standards for health professions education. This was
done first at the initial professional degree level (MD,
BSN)) and later this was extended to graduate and con-
tinuing education. Thus, it is not surprising that the
most common and widespread activity of NMAs today
is their involvement in educational standard setting.
There are some who continue to assert that profes-
sionalism (i.e. Miles, PV et al. [2] should be the sole, or
at least the predominant means of assuring quality.
However, empirical evidence, from seminal reports like
the 1999 report of the US Institute of Medicine [3], to
the widely cited study of McGlynn et al. [4] have sug-
gested that professionalism, while very important, is in-
sufficient to insure the highest quality of care possible
for a given level of expenditures. The growth of institu-
tional health care delivery (hospital, integrated delivery
systems) in ever larger aggregations, with many different
individuals and the institutions involved, has highlighted
the link between quality and the way in which care is or-
ganized and delivered.This is an Open Access article distributed under the terms of the Creative
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have presented a major challenge to NMAs, which are,
first and foremost, dues supported organizations of pro-
fessionals. While defining and promoting the concepts
of professionalism, they also must advocate the interests
of their members or risk being seen as irrelevant. The
emergence of specialty-focused medical organizations
(and with medical specialty boards gaining the primary
allegiance of many physicians) has further splintered the
roles of the NMAs, even within the sphere of activities
usually covered within professionalism. In many cases,
specialty organization have begun to set at least some
clinical quality standards in the form of guidelines for
their members, and the many of the specialty boards
have established requirements for individual certifica-
tion. While the focus of Levi et al., is specifically on
NMAs, it may be useful to also include specialty soci-
eties and boards in future considerations and studies,
since it would seem that the objective is to ascertain the
level of control or at least the degree of influence that
physician organizations – of all types - have on quality.
In subsequent parts of this commentary, we will use the
term “organizations of medical professionals” (OMP’s) to
designate this larger sphere of influence.
In only a few of the health systems analyzed by Levi
(with Germany as the clearest example) does it appear
the NMAs have been a primary force in the expansion
of quality activities, beyond setting and monitoring edu-
cational standards. Only in a few countries have NMAs
been involved in the full spectrum of measurement,
feedback, benchmarking and goal setting, and increas-
ingly, linking performance to physician or health entity
payment. In the US at least, while the AMA has played
important roles (along with other physician-dominated
groups) in undergraduate, graduate and continuing edu-
cation, some of the subspecialty societies and boards
have played broader and more extensive roles in quality
management than the AMA.
Without an extensive analysis of the evolution of qual-
ity activities in each country, and the roles that were
played by OMPs, it is impossible to say why these
groups have not been in leadership positions, and why
they have not assumed more influence across broader
domains of quality improvement. However, I would offer
that the factors probably included some combination of
the following:
1. Many OMPs appear to have assumed a more
reactive than proactive role in defining and
implementing quality and quality improvement,
even in the area that most OMPs controlled, that
of CME. This may have been in part due to the
inherent conflict between being advocates for
physicians, and recognizing that there are majorgaps in the quality and safety of medical care. There
may also have been an assumption, especially by
those who have pushed for a larger role of public
funding and involvement in health care, that “he
who pays the piper calls the tune” – resulting in
government oversight being seen as a first line of
responsibility for insuring quality of care. While
some groups, as for example the American Board
of Medical Specialties have now expanded professional
norms to include a commitment to “lifetime continuous
learning” (including recertification at defined intervals),
others have remained on the sidelines.
2. The limited resources available to OMPs
(as contrasted with governments, or in the US,
employers and private insurers) for funding
development of quality improvement activities may
also have played an important role. This is especially
significant because, in the past, quality reviews have
often involved very time and labor intensive, and
therefore expensive, reviews of paper records. In
addition, t implementing and disseminating quality
reports can also be quite costly.
3. Another barrier has probably been the fragmentation
of physician interests from National Medical
Associations to an ever increasing number of medical
specialty and sub-specialty organizations, and in some
cases special interest groups (in the US this includes
groups based on gender, race and ethnicity).
Another set of factors influencing OMP participation
has been the rather haphazard and uneven emergence of
both private and public sector quality regulatory and
accrediting bodies. In the US, the Joint Commission (JC)
began accrediting hospitals in 1951 as a successor to the
hospital minimum standards program of the American
College of Surgeons, which actually got its start from the
work of Codman in the early 1900s. The forces that re-
sulted in the creation the JC included both a sincere de-
sire to extend some of the norms of professionalism
(standards) to institutional healthcare, as well as a desire
to avoid government interventions in regulating quality,
especially at the institutional level. The AMA, along
with some of the major specialty organizations (most
notably internal medicine and surgery) played vital roles
in the creation of the JC, and have largely controlled its
board and direction since then.
The development of public sector regulation can be
traced largely to 1965 when CMS (then HCFA) was
given power in the original Medicare legislation of 1965
to set “conditions of participation” for hospitals and
nursing homes (but in part due to AMA opposition,
NOT physician practices) in the Medicare and Medicaid
programs of public insurance. The legislation also gave
the JC exclusive “deemed status” with CMS, so that
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conditions for participation in the Medicare program.
Thus the creation and expansion of the JC allowed a co-
alition of physician organizations to essentially control
hospital accreditation, at least up to the time of the im-
plementation of Medicare, with its hospital “conditions
of participation” (i.e. standards).
By contrast, the formation of the National Committee
for Quality Assurance, in 1990, whose initial board and
direction was controlled by executives of health plans
and large employers. It is important to note that since
that time the NCQA board has evolved to be a broad
based group of health care leaders with only one or two
of 15 or so members being from health plans. NCQA
also began early in it's existence to develop and then
publicly report empirical measures of health care in its
HEDIS data set. Thus the formation and evolution of
NCQA did not, like the JC, involve control of accredit-
ing bodies by organized physician groups.
On the public side, it is important to note the creation
of AHRQ (which in 1989 was created as the Agency for
Health Care Policy and Research-AHCPR) and the ex-
pansion of CMS’s role in assurance organizations in the
quality area. The growth of AHRQ, along with the estab-
lishment of a public-private partnership organization,
the National Quality Forum (whose primary role is in
endorsing and promulgating measures in both the public
and private sectors), and the establishment of the Insti-
tute for Healthcare Improvement (IHI-a private sector
organization focused on education and implementation
of quality improvement efforts) have marked a rapid ex-
pansion of quality efforts in the US.
Indeed, in the past decade, there has been a prolifera-
tion of organizations, both public and private sector, that
have entered the quality arena. It would seem that at this
point in time, in the US and a number of other coun-
tries, this proliferation calls for a reassessment and an
attempt at some coherence, including a clarification of
the role and importance of involving OMPs. To ascer-
tain further directions for OMPs in quality, it may be
helpful to look at where the field of quality in healthcare
is heading. For example,
1. Quality improvement is increasingly seen to be a
critical component of health care delivery
2. There is a trend towards larger and more complex
delivery systems in most countries,
3. The government’s role in financing and payment is
large in most countries, and increasing in others
(like the US)
4. The practice of medicine is becoming ever more
complex and rapidly changing.
5. Even in healthcare systems that are totally
government financed and delivered, patients andthe healthcare professionals, along with the public
at large, remain key stakeholders
A few potential directions for OMPs include:
1. Updating the concept of professionalism.
Professionalism is still an important and for most, a
desirable contract between society and those who
provide certain kinds of services like medicine.
However, professionalism as a concept evolved in
the era before insurance, and before the recognition
of the critical interests of purchasers, payers, and
taxpayers and others beyond just the doctor and
patient. In recent years the American Board of
Internal Medicine and the American College of
Physicians, along with the some International
medical organizations have worked at redefining
the implicit contract between physicians and both
patients and other stakeholders in health care [5].
While still lacking substantial input from non-
medical stakeholders including patients, it has
defined a new spectrum of professionalism which
includes active involvement in Qi and a commitment
to “lifelong learning” (well beyond just CME).
2. Expanding the role of OMAs in the quality arena.
Just as some advocates for patient involvement, such
as Don Berwick, have called for “nothing done to
me, without me” [6], it should be recognized that
health professionals as represented in OMAs, should
be directly involved in and influencing (but not
necessarily controlling), all aspects of quality
improvement. These include the development of
guidelines, measures or clinical decision support,
measurement and reporting, or efforts at continuous
professional development. This will require major
rethinking by some of those controlling the processes,
and a concerted leadership and coordination of roles
and efforts between NMAs, medical specialty
societies, and medical specialty boards.
3. Expanding the efforts of NMAs to actively engage
their members in quality improvement leadership
and activities- as well as in trying to shape and
influence the direction of outside efforts- in maintain-
ing a strong clinical focus on QI work. For example,
in the US, the AMA has recently increased its focus
on quality improvement by making it one of three
key strategic foci for AMA. This has resulted in major
pushes by the AMA to improve care for diabetes and
heart disease in close collaboration with other group,
as well as in sponsorship (and convening) of the
Physician Collaborative for Practice Improvement
and National Quality Registry Network.
In summary, as Levi et al. [1] have noted, the roles of
NMA and the expanded spectrum of physician organizations
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volvement and support for quality of care related efforts is
critical if we are to truly integrate quality into the everyday
practice of medicine, and in health care in general.
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